PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: vesna.munic.kos@ki.se.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(20)30775-710.1016/j.biopha.2020.110582
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 32763818
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32763818>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32763818>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all